NIH public-private partnership to advance early interventions for schizophrenia
Wednesday, September 16, 2020 - 14:31
in Psychology & Sociology
The National Institutes of Health is launching a new public-private partnership to meet the urgent need for early therapeutic interventions for people at risk of developing schizophrenia. Part of the Accelerating Medicines Partnership (AMP), AMP Schizophrenia (SCZ) brings together NIH, the U.S. Food and Drug Administration and multiple non-profit and private organizations. These partners will work […]